Title
Prostate specific antigen
Document Type
Article
Publication Date
2011
Abstract
The use of PSA as a screening test for prostate cancer remains controversial because no double blind, randomised controlled trial has shown that early detection reduces mortality.1,2 Despite this controversy, PSA provides valuable information for the general practitioner in everyday clinical practice, including monitoring of treated and untreated prostate cancer and prostatitis.
Recommended Citation
Brett, T. (2011). Prostate specific antigen. Australian Family Physician, 40(7), 497-500.
Letter to editor MK.pdf (220 kB)
COinS
Comments
Due to copyright restrictions the publisher's version/PDF of this article is unavailable for download.
This article may be accessed from the publisher here
Australian Family Physician may be accessed from the National Library of Australia here